e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reversible pulmonary hypertension associated with multivisceral Whipple's disease
Alice Camboulive, Etienne-Marie Jutant, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Charlotte Mussini, Jérémie Bénichou, Jean-Christophe Lagier, Marc Humbert, David Montani
Source:
Eur Respir J, 57 (2) 2003132; 10.1183/13993003.03132-2020
Journal Issue:
February
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alice Camboulive, Etienne-Marie Jutant, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Charlotte Mussini, Jérémie Bénichou, Jean-Christophe Lagier, Marc Humbert, David Montani. Reversible pulmonary hypertension associated with multivisceral Whipple's disease. Eur Respir J, 57 (2) 2003132; 10.1183/13993003.03132-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Pulmonary hypertension associated with Whipple disease
Source: Eur Respir Rev 2014; 23: 533-536
Year: 2014
Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease
Source: Eur Respir J 2005; 26: 969-972
Year: 2005
Whipple’s disease: a rare and life-threatening cause of pulmonary hypertension
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021
Pulmonary involvement in behcet's disease
Source: Eur Respir J 2002; 20: Suppl. 38, 63s
Year: 2002
Pulmonary complications of Behcet disease
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
Pulmonary arterial hypertension associated with congenital heart disease
Source: Eur Respir Rev 2012 21: 328-337
Year: 2012
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009
Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012
Pulmonary veno-occlusive disease
Source: Eur Respir J 2016; 47:1518-1534
Year: 2016
Pulmonary arterial hypertension masquerading as severe refractory asthma
Source: Eur Respir J 2008; 32: 513-516
Year: 2008
Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease
Source: Eur Respir J 2015; 45: 842-845
Year: 2015
Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006
Pulmonary hypertension in end-stage renal disease and post renal transplantation patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Pulmonary manifestations in Crohn's disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=151
Year: 2005
Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007
Nebulised Iloprost for pulmonary arterial hypertension associated with congenital heart disease: one centre's experience
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001
Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
Source: ERJ Open Res, 5 (1) 00168-2018; 10.1183/23120541.00168-2018
Year: 2019
Vascular, pulmonary and cardiac involvement in Behcet’s disease
Source: Eur Respir J 2004; 24: Suppl. 48, 279s
Year: 2004
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept